Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Shengxiang Ren, Caicun Zhou, Jianjun Zou et al.|Journal of Thoracic Oncology|2021

Cited by 311